Mendoza, Jillian .
HRN: 27-84-54 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/28/2026
AMPICILLIN 500MG (VIAL)
02/28/2026
03/06/2026
IV
280MG
Q6
URTI
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: URTI Compliance to guidelines: